Loading…
Centuple Global (BSE 531099)₹31.98−0.84%Pharmaceuticals
Centuple Global is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 11.6 against a peer median of 22.3, and ROCE of 15.0% against a peer median of 5.0%, and latest-quarter sales growth of 1,07,642.3% against a peer median of −12.9%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Welcure Drugs & Pharmaceuticals | 24 | — | −3.0 | −5.5 | 0.00 | 0.0 | 366 | −5 | −100.0 | −1,768.9 | vs BSE 531099 |
| Walpar Nutritions | 24 | 9.5 | 14.9 | 13.9 | 0.89 | 0.0 | 79 | 3 | 7.8 | 6.4 | vs BSE 531099 |
| Ishita Drugs & Industries | 22 | 28.3 | 8.6 | 7.0 | 0.01 | 0.0 | 15 | 1 | −32.8 | −36.7 | vs BSE 531099 |
| Venmax Drugs & Pharmaceuticals | 21 | 54.3 | 3.0 | 2.7 | 0.02 | 0.0 | 8 | 0 | 1,128.1 | −87.0 | vs BSE 531099 |
| Span Divergent | 20 | — | −30.0 | −41.5 | 0.48 | 0.0 | 17 | −3 | −4.6 | — | vs BSE 531099 |
| Mono Pharmacare | 18 | 52.6 | 5.0 | 1.1 | 1.78 | 0.0 | 166 | 0 | 22.1 | −100.0 | vs BSE 531099 |
| Centuple Global | 18 | 11.6 | 15.0 | 12.7 | 0.29 | 0.0 | 575 | 2 | 1,07,642.3 | −1,040.0 | — |
| Colinz Laboratories | 18 | 6.4 | 7.2 | 5.3 | 0.04 | 0.0 | 6 | 1 | −21.2 | 1,753.8 | vs BSE 531099 |
| Zenith Health Care | 17 | — | 0.3 | 0.1 | 0.00 | 0.0 | 10 | 0 | −23.7 | −430.0 | vs BSE 531099 |
| Starsource Multitrade | 17 | — | −163.9 | −164.0 | 0.00 | 0.0 | 1 | −12 | — | — | vs BSE 531099 |
| Desh Rakshak Aushdhalaya | 14 | 22.3 | 6.6 | 4.9 | 0.21 | 0.0 | 7 | 1 | −21.5 | −17.1 | vs BSE 531099 |
| Peer median | 18 | 22.3 | 5.0 | 2.7 | 0.04 | 0.0 | 15 | 0 | −12.9 | −87.0 |
Listed companies closest to Centuple Global in Pharmaceuticals include Welcure Drugs & Pharmaceuticals, Walpar Nutritions, Ishita Drugs & Industries, Venmax Drugs & Pharmaceuticals, Span Divergent, Mono Pharmacare, Colinz Laboratories, Zenith Health Care.
Welcure Drugs & Pharmaceuticals, with a market cap of ₹23.56 Cr.
Centuple Global trades at a P/E of 11.6; the median of its peer set is 22.3. A P/E above or below the median is a description, not a judgement on value.
Centuple Global's return on capital employed is 15.0%, above the peer median of 5.0%.